BERNS PAUL L 4
4 · Neumora Therapeutics, Inc. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
BERNS PAUL L
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2026-01-08+1,650,000→ 1,650,000 totalExercise: $2.33Exp: 2036-01-08→ Common Stock (1,650,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 8, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.